BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Acadia  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist 





 Company News
Sunovion Pharmaceuticals Inc. Announces Health Outcomes Data That Support The Consideration Of Brovana (Arformoterol Tartrate) Inhalation Solution For The Maintenance Treatment Of COPD At The American Thoracic Society (ATS) 2015 Annual Meeting 5/21/2015 12:12:07 PM
Sunovion Pharmaceuticals Inc. Announces Positive Results for Latuda(Lurasidone HCL) In First Placebo-Controlled Trial Of Patients With Major Depressive Disorder With Mixed (Subsyndromal Hypomanic) Features 5/20/2015 12:18:40 PM
Sunovion Pharmaceuticals Inc. To Present New Clinical Analysis And Health Outcomes Data Supporting Use Of BROVANA In Patients With Moderate-To-Severe COPD At The 110th American Thoracic Society Annual Meeting 5/6/2015 11:14:20 AM
MassBioEd Foundation Partners With Sunovion Pharmaceuticals Inc. To Advance Science Education In High Schools 4/28/2015 12:36:23 PM
Sunovion Pharmaceuticals Inc. To Present Data On Aptiom (eslicarbazepine acetate) At 67th American Academy of Neurology Annual Meeting 4/14/2015 11:42:39 AM
Sunovion Pharmaceuticals Inc. Announces Initiation Of Phase 3 Clinical Trial Program For SUN-101/Eflow (Glycopyrrolate) In Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease (COPD) 2/25/2015 10:34:51 AM
PsychoGenics Inc. Achieves Another Milestone In Drug Discovery Collaboration With Sunovion Pharmaceuticals Inc. 1/27/2015 8:06:52 AM
Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda® 1/15/2015 10:12:39 AM
Sunovion Pharmaceuticals Inc. Announces FDA Acceptance For Review Of Supplemental New Drug Application For The Use Of AptiomĀ® (Eslicarbazepine Acetate) As Monotherapy Treatment For Partial-Onset Seizures 1/7/2015 10:35:59 AM
Sunovion Pharmaceuticals Inc. Release: Investigational Drug Dasotraline Significantly Improved Symptoms Of Attention Deficit Hyperactivity Disorder (ADHD) In A Placebo-Controlled Study In Adults 12/11/2014 8:14:35 AM
12345678910...